Cardiomox MCG-9  

enabling  cardiovascular diagnostics at an early stage  

DSC_5106 cut

Why use our device? 

  • Highly sensitive method
  • Robust AI-driven differential diagnosis
  • Fast and non-invasive procedure 
  • Earlier detection of medical condition
  • Improved patient outcome 

The technology

New generation magnetocardiography uses a powerful medical device to detect weak current signals emitted by the cardiac muscle cells. The procedure is fast, simple and non invasive. Coupled with smart software, it allows the generation of current density vectors images revealing the electrophysiological state of the heart. Given its high sensitivity, this method allows detection of abnormal current symptomatic of cardiac conditions, at rest enabling early diagnosis of heart disease.


Image curtesy of

The heart’s magnetic field

SQUIDs (Superconductor quantum interference device) are the best-suited sensors to record the magnetic fields arising from the electrical activity of the human heart. They allow spatially and temporally accurate measurements of the very weak magnetic fields produced by currents flowing through the myocardial fibres during cardiac activity. These currents can be axial, tangential and vortex. Vortex currents are not detectable by ECG, as a result Cardiomox’s MCG-9 is able to uniquely detect the direction and magnitude of the field to monitor the electrophysiological activity of the patient’s heart  allowing differential detection of abnormal current symptomatic of cardiac conditions. 

Intelligent software

Analysis software has represented a major hurdle in the application of MGC to cardiology. This is why Cardiomox has broadened their research above and beyond the MCG device itself. Not only did they develop intelligent software to analyse the data but they have also focussed on identifying reliable markers allowing differential diagnosis.